Strong trader consensus against a new pandemic in 2026 reflects the absence of any novel pathogen exhibiting sustained global human-to-human transmission capable of meeting WHO pandemic criteria. The dominant factor is the ongoing Bundibugyo virus Ebola outbreak in the Democratic Republic of the Congo, declared a public health emergency of international concern but assessed by WHO as posing only low global risk outside affected African regions, with over 7,400 confirmed cases and declining transmission in key epicenters like Ituri despite localized surges elsewhere. Concurrent mpox activity remains moderate-risk and regionally concentrated, while influenza, SARS-CoV-2, and other respiratory viruses show stable low positivity rates per global surveillance. Enhanced post-COVID surveillance, contact tracing, and the advancing WHO Pandemic Agreement further support containment. Realistic challenges include viral mutation enabling broader spread or an undetected zoonotic spillover evading current monitoring.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertNeue Pandemie im Jahr 2026?
Ja
$1,105,076 Vol.
$1,105,076 Vol.
Ja
$1,105,076 Vol.
$1,105,076 Vol.
The resolution source will be official announcements from the World Health Organization.
Markt eröffnet: Dec 1, 2025, 4:37 PM ET
Abwickler
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Abwickler
0x65070BE91...Strong trader consensus against a new pandemic in 2026 reflects the absence of any novel pathogen exhibiting sustained global human-to-human transmission capable of meeting WHO pandemic criteria. The dominant factor is the ongoing Bundibugyo virus Ebola outbreak in the Democratic Republic of the Congo, declared a public health emergency of international concern but assessed by WHO as posing only low global risk outside affected African regions, with over 7,400 confirmed cases and declining transmission in key epicenters like Ituri despite localized surges elsewhere. Concurrent mpox activity remains moderate-risk and regionally concentrated, while influenza, SARS-CoV-2, and other respiratory viruses show stable low positivity rates per global surveillance. Enhanced post-COVID surveillance, contact tracing, and the advancing WHO Pandemic Agreement further support containment. Realistic challenges include viral mutation enabling broader spread or an undetected zoonotic spillover evading current monitoring.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert



Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen